CURE: Digestive Diseases Research Center

Research Focus

CURE: Digestive Diseases Research Core Center (CURE:DDRCC) is composed of a cohesive group of physicians and basic scientists with strong independent peer-reviewed grant-supported research programs in the biology of the gut, with special emphasis on regulation of mucosal cell function, enteric neuroscience and signal transduction mechanisms. CURE, created in 1974, has grown and evolved into a broadly based gastrointestinal research organization with multiple affiliations, principally the VA and UCLA.

The research programs of the CURE: DDRCC members can be broadly divided into four major areas:

  • gastroduodenal mucosal physiology and disease
  • intestinal and pancreatic physiology and disease
  • neural regulation of gastroenteric function and neuroenteric disease
  • mechanism of action of gastrointestinal peptides, including receptor regulation, signal transduction and control of cell proliferation

The Biomedical Research Cores of CURE: DDRCC provide access to modern cellular imaging to study signaling proteins and their functions, animal models for studying physiology and pathogenesis, molecular vectors to express a wide variety of proteins and access to a broad range of techniques and patients for clinical studies. The Administrative Core provides a wide range of support for center activities, including a comprehensive and multidisciplinary enrichment program. The Pilot and Feasibility Study and Named New Investigator programs have provided a successful mechanism for promoting the development of new programs in digestive diseases-related research, primarily by young investigators. The Center provides an optimal environment for cooperation and collaboration among its investigators, who have had a major impact on digestive disease research over the past three decades.